Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00682_DB06268_nanopub.RAdR5q3k3_yQR-cwnX54IJyApq3AsbrABuseD_vdPyJU8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00682_DB06268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00682_DB06268 label "DDI between Warfarin and Sitaxentan - Sitaxentan, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Warfarin doses should be decreased by 80% upon initiated of concomitant therapy. Monitor for changes in the therapeutic and adverse effects of warfarin if sitaxentan is initiated, discontinued or dose changed. [drugbank_resource:DB00682_DB06268]" assertion.
- drugbank_resource:DB00682_DB06268 identifier "drugbank_resource:DB00682_DB06268" assertion.
- drugbank_resource:DB00682_DB06268 title "DDI between Warfarin and Sitaxentan - Sitaxentan, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Warfarin doses should be decreased by 80% upon initiated of concomitant therapy. Monitor for changes in the therapeutic and adverse effects of warfarin if sitaxentan is initiated, discontinued or dose changed." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB06268 assertion.
- drugbank:DB06268 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB06268 assertion.